These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18496721)

  • 1. IQWiG: an opportunity lost?
    Jönsson B
    Eur J Health Econ; 2008 Aug; 9(3):205-7. PubMed ID: 18496721
    [No Abstract]   [Full Text] [Related]  

  • 2. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Health economics and HTA].
    Kulp W; Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic data transferability for HTA: are we there yet?
    Manca A
    Value Health; 2009 Jun; 12(4):407. PubMed ID: 19900247
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions.
    Frederix GW; Haji Ali Afzali H; Dasbach EJ; Ward RL
    Pharmacoeconomics; 2015 Aug; 33(8):777-81. PubMed ID: 25827099
    [No Abstract]   [Full Text] [Related]  

  • 6. How do cardiologists face health economics and health technology assessments?
    Boriani G
    Eur Heart J; 2012 Nov; 33(22):2757-8. PubMed ID: 23297423
    [No Abstract]   [Full Text] [Related]  

  • 7. To use technology better.
    Garber AM
    Health Aff (Millwood); 2006; 25(2):w51-3. PubMed ID: 16464903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic evaluation: in need of more analytical rigor or more practical relevance?
    Rovithis D
    Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):107-10. PubMed ID: 19402796
    [No Abstract]   [Full Text] [Related]  

  • 9. Making the cut. High price tags for state-of-the art surgical equipment have hospitals weighing when or even whether to invest.
    Gardner E
    Mod Healthc; 2006 Feb; 36(7):50-2, 54, 56. PubMed ID: 16515075
    [No Abstract]   [Full Text] [Related]  

  • 10. Health technology assessment in Scotland.
    Kohli HS
    Natl Med J India; 2003; 16(5):275-6. PubMed ID: 14680286
    [No Abstract]   [Full Text] [Related]  

  • 11. Health technology assessment (HTA) groups have been instrumental in restricting patient access to PET worldwide.
    Ware R
    J Nucl Med; 2004 Dec; 45(12):1977. PubMed ID: 15641205
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology assessment and the doctor-patient relationship.
    Wax AL
    Va Law Rev; 1996 Nov; 82(8):1641-62. PubMed ID: 16715567
    [No Abstract]   [Full Text] [Related]  

  • 13. Advantages and disadvantages of discrete-event simulation for health economic analyses.
    Caro JJ; Möller J
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):327-9. PubMed ID: 26967022
    [No Abstract]   [Full Text] [Related]  

  • 14. Is high-tech treatment worth the cost?
    Kastiel DL
    Bus Insur; 1985 Nov; 19(44):30. PubMed ID: 10274034
    [No Abstract]   [Full Text] [Related]  

  • 15. Transparency of economic evaluations of health technologies.
    Rovira J
    Pharmacoeconomics; 2008; 26(3):181-3. PubMed ID: 18282013
    [No Abstract]   [Full Text] [Related]  

  • 16. [When new methods are about to be introduced].
    Graff BA; Thürmer H; Søreide O; Norderhaug IN
    Tidsskr Nor Laegeforen; 2008 Feb; 128(4):472. PubMed ID: 18274585
    [No Abstract]   [Full Text] [Related]  

  • 17. A determination of topics for health technology assessment in Thailand: making decision makers involved.
    Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten arguments for a societal perspective in the economic evaluation of medical innovations.
    Jönsson B
    Eur J Health Econ; 2009 Oct; 10(4):357-9. PubMed ID: 19618224
    [No Abstract]   [Full Text] [Related]  

  • 19. A short history of health technology assessment in Germany.
    Perleth M; Gibis B; Göhlen B
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():112-9. PubMed ID: 19500440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.